ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
0.00%
US Tech 100
20,135.60
0.09%
Dow Jones
39,721.36
0.00%
Brent Oil
84.505
-0.64%
Bitcoin
58,671.11
1.58%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clearside Biomedical Inc (CLSD) Quote

Clearside Biomedical Inc

Clearside Biomedical Inc (CLSD)

NASDAQ
1.23
-0.03
(-2.38%)
Closed July 10 4:00PM
Delayed by 15 minutes
1.23
0.00
( 0.00% )
Pre Market: 7:21AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.23
Bid
1.10
Ask
1.30
Volume
14
0.00 Day's Range 0.00
0.650101 52 Week Range 2.12
Market Cap
91.919M
Previous Close
1.23
Open
-
Last Trade
9
@
1.27
Last Trade Time
08:44:24
Financial Volume
-
VWAP
-
Average Volume (3m)
185,265
Shares Outstanding
74,731,139
Dividend Yield
-
PE Ratio
-2.83
Earnings Per Share (EPS)
-0.43
Revenue
8.23M
Net Profit
-32.49M

About Clearside Biomedical Inc

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.clearsidebio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Clearside Biomedical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLSD. The last closing price for Clearside Biomedical was $1.23. Over the last year, Clearside Biomedical shares have traded in a share price range of $ 0.650101 to $ 2.12.

Clearside Biomedical currently has 74,731,139 shares outstanding. The market capitalization of Clearside Biomedical is $91.92 million. Clearside Biomedical has a price to earnings ratio (PE ratio) of -2.83.

CLSD Latest News

More News

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.Ā (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

2 hours ago
GlobeNewswire Inc.

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for...

June 27 2024
GlobeNewswire Inc.

Clearside Biomedicalā€™s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - Robust Safety Profile and Encouraging Efficacy Data Reported Utilizing SCS MicroinjectorĀ® - ALPHARETTA...

June 12 2024
GlobeNewswire Inc.

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCSĀ®) Injection in Leading Peer-Reviewed Industry Journal, RETINAĀ®

- Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience...

May 21 2024
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

May 10 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 09 2024
Edgar (US Regulatory)

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

- Phase 2b ODYSSEY Trial in Wet AMD Remains on Track with Topline Data Expected Q3 2024 - - Strengthened Management Team and Board of Directors with Two Key Additions -- Management to Host...

May 09 2024
GlobeNewswire Inc.

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.Ā (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

May 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-2.380952380951.261.31.21311141.25692384CS
40.032.51.21.3111818081.19872206CS
12-0.05-3.906251.281.5211852651.28892593CS
26-0.2-13.9860139861.432.1212753541.46015194CS
520.1716.03773584911.062.120.6501012098131.31236943CS
156-4.22-77.43119266065.457.730.6501013270562.55278871CS
2600.1311.81818181821.17.730.565790292.8537973CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.41
(98.28%)
17.43M
VLCNVolcon Inc
$ 6.54
(79.18%)
9.82M
RNLXRenalytix PLC
$ 0.4777
(58.23%)
39.65M
HSCSHeart Test Laboratories Inc
$ 6.76
(52.94%)
302.17k
BSFCBlue Star Foods Corporation
$ 2.53
(50.60%)
15.13M
IVPInspire Veterinary Partners Inc
$ 5.3887
(-27.18%)
284.32k
SLRXSalarius Pharmaceuticals Inc
$ 2.15
(-21.60%)
1.52M
AGBAAGBA Group Holding Ltd
$ 2.04
(-21.54%)
610.11k
OABIOmniAb Inc
$ 3.27
(-20.82%)
8
HUBCWHub Cyber Security Ltd
$ 0.019
(-19.83%)
100
KZIAKazia Therapeutics Ltd
$ 1.00
(49.66%)
43.17M
RNLXRenalytix PLC
$ 0.4777
(58.23%)
39.65M
MAXNMaxeon Solar Technologies Ltd
$ 0.1945
(-7.73%)
26.3M
PRSTPresto Technologies Inc
$ 0.0775
(0.65%)
18.34M
BDRXBiodexa Pharmaceuticals PLC
$ 1.41
(98.28%)
17.43M

CLSD Discussion

View Posts
Monksdream Monksdream 5 days ago
CLSD under $2
šŸ‘ļø0
Monksdream Monksdream 2 months ago
CLSD under $2
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
I'll suggest now that the GAP FILLED yesterday and it takes news 2-3 days to be digested, tomorrow we hopefully head back to the 2$ area, just my WAG bwthdik
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
WHO KNOWS PARD WHO KNOWS
👍️ 1
BBANBOB BBANBOB 4 months ago
.
šŸ‘ļø0
jhdf51 jhdf51 4 months ago
Great..well maybe just maybe we are finally on our way albeit perhaps a bumpy ride...

JHD
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
JHD

NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2

Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
šŸ‘ļø0
jhdf51 jhdf51 4 months ago
Same ol same ol
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
WE BOTH HAVE THE SAME PROBLEM

DNDN been there done that and not again
👍️ 1
BBANBOB BBANBOB 4 months ago
.53 cent loss versus .55 loss last yr
šŸ‘ļø0
jhdf51 jhdf51 4 months ago
Yep..I was thinking of getting out but same...
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
Not REAL THRILLED with the earnings to be released AH's that is normally indicative of bad numbers, so looks like the 2.12 was a head fake for some to get out
I came close to selling 50% yesterday and get back in when it closes the gap @ 1.54,,,,,,, but just couldn't find the CAJONES to do it..........OH WELL NO BALLS NO BLACK CHIPS
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
Appears they are playing this real hard to get shares all the way to 1.81 from 2.12
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
1.87 NEW annual high and HOD. 3 trade days ago we did 3 mill shares and VOL proceeds PPS

MY WAG is this is over 2$ by weeks end.

AND NO not pumping this since I have held it for over 2 yrs NOV of 2022 and @ $4.86 finally got my avg to $2.00
šŸ‘ļø0
Monksdream Monksdream 4 months ago
CLSD 10Q due March 12
šŸ‘ļø0
Monksdream Monksdream 4 months ago
CLSD new 52 week hi
šŸ‘ļø0
glenn1919 glenn1919 4 months ago
CLSD....................................................https://stockcharts.com/h-sc/ui?s=CLSD&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
BBANBOB BBANBOB 4 months ago
And on VERY GOOD VOL, me thinks something is up
šŸ‘ļø0
Monksdream Monksdream 4 months ago
CLSD new 52 week high
šŸ‘ļø0
Monksdream Monksdream 5 months ago
CLSD under $2
šŸ‘ļø0
BBANBOB BBANBOB 6 months ago
OOOOOOOOOOOOOPS $1.47
šŸ‘ļø0
BBANBOB BBANBOB 9 months ago
OPPPPPPPPPPPPPPS .6951
šŸ‘ļø0
BBANBOB BBANBOB 9 months ago
APPEARS we just made a new one too DAMN @ .70

I'm hoping they are tanking it in front of good earning to pick it up I KNOWWWWWWWWWWWWWWWWWWWWWWWWWWWW
šŸ‘ļø0
Monksdream Monksdream 10 months ago
CLSD new 52 week low
šŸ‘ļø0
Monksdream Monksdream 10 months ago
CLSD new 52 week low
šŸ‘ļø0
Monksdream Monksdream 10 months ago
CLSD new 52 week low
šŸ‘ļø0
Monksdream Monksdream 10 months ago
CLSD new 52 week low
šŸ‘ļø0
heyitsmeagain heyitsmeagain 2 years ago
Here we go
šŸ‘ļø0
heyitsmeagain heyitsmeagain 2 years ago
Loaded for this runner. Wish I had more loot.
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Hard to Borrow is back on CLSD today
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
FYI

THE HARD TO BORROW classification(at Schwab) just went POOF GHONDI as of today on CLSD and at the same time its is up 3.81%

HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Well so far so good !!!!!!!!!!!!!!!!!! Let's say for grins $3 on Fri
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Well well let's give this news 2-3 days to digest and see where it is by weeks end.

Also if if if this is gonna take off as I believe, the first part of the week MIGHT JUST SCARE THE WEAK here.

If you're faint at heart or can't handle pressure, one might want to JUST NOT LOOK for the next few days
šŸ‘ļø0
jhdf51 jhdf51 2 years ago
Now that would be perfect. Iā€™d hire me a farm hand, or two, or three! Lol

JHD
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Again

Earnings was a beat and they were .31 for the LAST quarter PER SHARE, do that X's a whole yr and then X's a multiple of 10-12 and there ya have it.

NOW Since this appears to be JUST the start of licensing, who knows how many more licenses will be entered into in the next year.

MY PPS prediction would be along the lines of $27-$35 in the next 12 months WAG and IMHO
šŸ‘ļø0
jhdf51 jhdf51 2 years ago
Yes I agree. Definitely could be. Dang Price targets are never exact anyway.
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
I'll take $9 for this year, but still say it will be more.
šŸ‘ļø0
jhdf51 jhdf51 2 years ago
I see $9. $18 was last year.

https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nasdaq-clsd-a-buy-or-sell-right-now-2022-03-2/amp/
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
But all companies good or bad always have HEDGE FUNDS that short their stock, THUS the meaning of HEDGE, being on both sides of the trade, much like a BOOKIE taking sports bets will take EITHER SIDE of a bet.

BUT unlike a bookie that takes your bet and at half time IS WAY UPSIDE down on the bet he made with you, HE DOES NOT HAVE THE OPPORTUNITY to CHANGE his bet, SHORTS DO at any given time

THUNK ABOUT IT BOYZZZZZZZZZZZ
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
SHORTS

Again as I did last week, I would serious suggest that you close even the few shorts you have still open here, as it might get REAL NASTY if ya don't, JUST SAYING
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Having NOT been able to take part in PICKING UP SHARES last week, I just got back to even as of today at one point. IF IF IF it closes over 2.39 today, then FINALLY again I am BACK in the black.
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
Well YET AGAIN it seems my 3 day rule on it taking 3 days for news to be fully digested before a stock rises,has yet again proven itself true..
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
CRUDEOIL

I have always suggested on these boards that, ""IT TAKE 3 days for news to be really digested before ya see real up swings, HMMMMMMMM
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
OH I agree 100% and suggested that ALL for the last months JUST SIT ON THEIR HANDS or add.....

Me aint got no dry powder or I would have last week and large
šŸ‘ļø0
crudeoil24 crudeoil24 2 years ago
Good earnings, & good technical indicators > CLSD momo/fomo taking us higher!
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
YEPPERS and so we have 4 months left there to meet the 1 yr
šŸ‘ļø0
crudeoil24 crudeoil24 2 years ago
Wedbush target is $18.00 > their PT is for one year!

CLSD
šŸ‘ļø0
jhdf51 jhdf51 2 years ago
No worries bud. I just appreciate being here and I believe we will see that raised by Wedbush again.

JHD
šŸ‘ļø0
BBANBOB BBANBOB 2 years ago
JHD

Thanks for the correction, sad we have some that POST OLD CHIT and even more sad THAT I DIDN'T CHECK it out further and took the bait and ran with it................................MY BAD !!!!!!!!!!!!

Still say though simply take .31 X's 4 ='s $1.24 and do that X's a PE of say 10 to 12 X's and you're pretty much there anyway......

Let the news digest for the 3 day rule (MY RULE) and see what the NEW ESTIMATES will be.........

Thank you again for keeping it straight that is all I want
šŸ‘ļø0
jhdf51 jhdf51 2 years ago
Yes from 2021. Currently $9 >> https://www.etfdailynews.com/2022/03/12/clearside-biomedical-nasdaqclsd-given-outperform-rating-at-wedbush/
šŸ‘ļø0

Your Recent History

NASDAQ
CLSD
Clearside Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved